(Q57618584)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Nicholas J Slevin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

J H Hendry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

R G Dale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J F Fowler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

T E Wheldon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

B Jones

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A J Munro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A G Robertson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

297-307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Idealized versus realized overall treatment times

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Actual versus ideal treatment time in radiotherapy for head and neck cancer: Catching up with the gaps

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Evaluation of unplanned interruptions in radiotherapy treatment schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The adverse effect of treatment prolongation in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Continuous or Split-Course Combined External and Intracavitary Radiotherapy of Locally Advanced Carcinoma of the Uterine Cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Loss of local control with prolongation in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Split-course versus continuous radiotherapy. Analysis of a randomized trial from 1964 to 1967.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Dose fractionation and tumour repopulation in radiotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Clinical radiobiology of squamous cell carcinoma of the oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Local control versus dose or overall time: from coefficients to percentages.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Radiobiological rationale for compensation for gaps in radiotherapy regimens by post-gap acceleration of fractionation.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Some common causes of treatment prolongation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Impact of spinal cord repair kinetics on the practice of altered fractionation schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Derivation and application of equations describing the effects of fractionated protracted irradiation, based on multiple and incomplete repair processes. Part 2. Analysis of mouse lung data

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Repair kinetics in pig epidermis: an analysis based on two separate rates of repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Two components of repair in irradiated kidney colony forming cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The time factor for late reactions in radiotherapy: repopulation or intracellular repair?

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Does the interval between fractions matter in the range of 4-8 h in radiotherapy? A study of acute and late human skin reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Dose-response relationships for late radiation effects in the head and neck: Regarding the analysis of the RTOG 8313 trial, fu et al IJROBP 32:577–588; 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

What degree of accuracy is required and can be achieved in photon and neutron therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Radiobiological considerations in the design of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The steepness of the dose response curve both for tumor cure and normal tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Relationship between early and late normal-tissue injury after postmastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Response of human organs to single (or fractionated equivalent) doses of irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

A proposed figure of merit for the assessment of unscheduled treatment interruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Steepness of the Clinical Dose–control Curve and Variation in thein VitroRadiosensitivity of Head and Neck Squamous Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The effect of treatment duration in the local control of cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Results of a questionnaire regarding the practice of radiotherapy for carcinoma of the cervix in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Case report: low dose rate and high dose rate intracavitary brachytherapy in a patient with carcinoma of the cervix.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

Dosimetric Precision Requirements in Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980715-0

7 January 2021

10.1016/S0936-6555(05)80715-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8934049%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference